Agios Pharmaceuticals (Germany) Probability of Future Stock Price Finishing Over 59.70
| 8AP Stock | EUR 52.50 1.50 2.94% |
Agios |
Agios Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Agios Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Agios Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Agios Pharmaceuticals had very high historical volatility over the last 90 days | |
| The company reported the revenue of 14.24 M. Net Loss for the year was (231.8 M) with profit before overhead, payroll, taxes, and interest of 140.39 M. | |
| Agios Pharmaceuticals has accumulated about 495.39 M in cash with (309.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.43. | |
| Over 99.0% of the company shares are owned by institutions such as pension funds |
Agios Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Agios Stock often depends not only on the future outlook of the current and potential Agios Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Agios Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.9 M | |
| Shares Float | 48.5 M |
Agios Pharmaceuticals Technical Analysis
Agios Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Agios Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Agios Pharmaceuticals. In general, you should focus on analyzing Agios Stock price patterns and their correlations with different microeconomic environments and drivers.
Agios Pharmaceuticals Predictive Forecast Models
Agios Pharmaceuticals' time-series forecasting models is one of many Agios Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Agios Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Agios Pharmaceuticals
Checking the ongoing alerts about Agios Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Agios Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Agios Pharmaceuticals had very high historical volatility over the last 90 days | |
| The company reported the revenue of 14.24 M. Net Loss for the year was (231.8 M) with profit before overhead, payroll, taxes, and interest of 140.39 M. | |
| Agios Pharmaceuticals has accumulated about 495.39 M in cash with (309.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.43. | |
| Over 99.0% of the company shares are owned by institutions such as pension funds |
Other Information on Investing in Agios Stock
Agios Pharmaceuticals financial ratios help investors to determine whether Agios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Agios with respect to the benefits of owning Agios Pharmaceuticals security.